EUCTR2016-002323-28-BE进行中(未招募)1 期
Blood concentration and pharmacokinetic analysis of propofol following administration of single induction dose in small children
niversitair Ziekenhuis Brussel0 个研究点目标入组 120 人开始时间: 2016年6月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Normal- weight and overweight children aged 1 to 4 years with American Society of Anesthesiology (ASA) physical status classification I or II scheduled to undergo elective surgical procedures under general anaesthesia, according to clinical practice at Universitair Ziekenhuis Brussel (UZBrussel) will be eligible as potential participants.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 120
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Children < 1 year and > 4 years of age
- •Children < 10 kg body weight
- •ASA physical status classification of = 3
- •Known allergy to propofol, soy bean oil or egg lecithin
- •Children with metabolic disorders
- •Children with hemato- oncologic diseases
- •Known renal disorders (as defined by 2x serum creatinine level for age and gender)
- •Known liver disorders (as defined by 2x serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) for age)
- •Children with epilepsy
- •Children presenting for an urgent surgery
- •Hemodynamic unstable children
- •Ventilated children
- •Children already receiving analgesics or sedatives prior to surgery
- •Children receiving total parenteral nutrition or other solutions containing high load fat emulsions
研究者
相似试验
招募中
不适用
Study on drug blood concentration, effectiveness, safety, and drug tolerance using residual samples of permission system and notification type antimicrobial druginfectious diseaseJPRN-UMIN000030456Keio University Hospital3,250
已完成
不适用
Analysis of pharmacokinetics and pharmacodynamics for capecitabine during new chemotherapy regimen by bevacizumab (Bev) in combination with XELOX in unresectable colorectal cancerunresectable colorectal cancerJPRN-UMIN000013038Tsukasa Hotta10
已完成
不适用
The examination of concentration of drug in tissues from the knee osteoarthritis patients who use the Esflurbiprofen tape or FlurbiprofeosteoarthritisJPRN-UMIN000024789Tokyo Medical and Dental University14
已完成
不适用
Population pharmacokinetics and pharmacodynamics of sorafenib in hepatocellular carcinoma patients with Child Pugh B liver cirrhosisliver cancer1001965410019815hepatocellular carcinomaNL-OMON44524Academisch Medisch Centrum45
已完成
不适用
Study about the relationship between ramosetron dose, plasma concentration and antiemetic effectKCT0001500Asan Medical Center51
